Breaking News Instant updates and real-time market news.

ICPT

Intercept

$119.58

3.14 (2.70%)

08:37
01/28/19
01/28
08:37
01/28/19
08:37

Intercept price target raised to $150 from $135 at Jefferies

Jefferies analyst Michael Yee raised his price target for Intercept Pharmaceuticals to $150 after reviewing scenarios for the company's Phase III nonalcoholic steatohepatitis data in February or March. The analyst sees a 65%-70% probability of "favorable scenarios" and sees the stock going to the $150-$225 range if the data "looks good." Further, it is possible that Intercept could be viewed as an acquisition candidate, especially if hits fibrosis and cardiovascular "is clean," Yee tells investors in a research note. If Intercept hits on both endpoints and safety is "balanced/clean," which the analyst assigns a 25%-35% probability, he sees the stock going to $175 to $225. However, if the company misses both endpoints and/or has safety issues, which the analyst assigns a 30%-35% probability, he thinks the stock goes to $35-$50. Yee keeps a Buy rating on Intercept Pharmaceuticals.

  • 18

    May

ICPT Intercept
$119.58

3.14 (2.70%)

01/14/19
LDLW
01/14/19
UPGRADE
Target $130
LDLW
Buy
Intercept upgraded to Buy from Hold at Laidlaw
Laidlaw analyst Francois Brisebois upgraded Intercept Pharmaceuticals to Buy and raised his price target for the shares to $130 from $99. The company recently announced that its "highly anticipated" Phase 3 Regenerate topline interim analysis in nonalcoholic steatohepatitis with advanced fibrosis is anticipated in Q1 versus the prior guidance of second half of 2019, Brisebois tells investors in a research note. A readout at the earlier part of guidance is a "significant positive" as it represents management's ability to deliver on timelines for their main value driver, says the analyst. Brisebois sees Intercept's upcoming date readout as "relatively de-risked." He's also encouraged by Intercept's acquisition of Aralez Pharmaceuticals' license to develop and commercialize bezafibrate in the U.S.
01/23/19
UBSW
01/23/19
INITIATION
Target $130
UBSW
Buy
Intercept initiated with a Buy at UBS
UBS analyst Navin Jacob started Intercept Pharmaceuticals with a Buy rating and $130 price target. The company's Phase III Regenerate study of Ocaliva in nonalcoholic steatohepatitis, with a readout in Q1 of 2019, is a "true binary event" with a potential valuation swing of 60% in either direction, Jacob tells investors in a research note. The analyst sees a 65% chance of success for the trial. Jacob says Intercept shares have "significant risk but with potential for high reward."
01/24/19
NEED
01/24/19
UPGRADE
NEED
Buy
Intercept upgraded to Buy from Hold at Needham
01/24/19
NEED
01/24/19
UPGRADE
Target $150
NEED
Buy
Intercept upgraded to Buy from Hold at Needham
Needham analyst Alan Carr upgraded Intercept to Buy with a price target of $150. The analyst says that he has a positive outcome bias toward the company's expected top-line results guidance in its Phase 3 trial of obeticholic acid in Non-Alcoholic Steatohepatitis, or NASH, in the current quarter, citing the data from the Phase 2 FLINT trial completed in 2014. While he sees an "extensive competitive development pipeline behind the drug", Carr believes that Intercept's obeticholic acid is likely to be the first drug approved in this indication.

TODAY'S FREE FLY STORIES

FB

Facebook

$189.02

0.21 (0.11%)

, TWTR

Twitter

$39.97

-0.29 (-0.72%)

12:37
10/16/19
10/16
12:37
10/16/19
12:37
On The Fly
#SocialStocks: Facebook still advancing Libra, Twitter clarifies rules »

Welcome to…

FB

Facebook

$189.02

0.21 (0.11%)

TWTR

Twitter

$39.97

-0.29 (-0.72%)

SNAP

Snap

$13.68

-0.41 (-2.91%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 23

    Oct

  • 24

    Oct

  • 27

    Oct

  • 30

    Oct

IRM

Iron Mountain

$32.64

-0.135 (-0.41%)

12:35
10/16/19
10/16
12:35
10/16/19
12:35
Options
Iron Mountain put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Oct

  • 12

    Nov

AMZN

Amazon.com

$1,776.00

7.3 (0.41%)

12:33
10/16/19
10/16
12:33
10/16/19
12:33
Hot Stocks
U.K.'s CMA announces formal investigation of Amazon's Deliveroo investment »

The Competition and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Oct

  • 24

    Oct

  • 27

    Oct

  • 29

    Oct

  • 21

    Nov

NBEV

New Age Beverages

$2.73

(0.00%)

12:32
10/16/19
10/16
12:32
10/16/19
12:32
Hot Stocks
New Age Beverages says on Twitter that 'big news coming' for Nestea »

The official Twitter…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

12:30
10/16/19
10/16
12:30
10/16/19
12:30
General news
FX Action: USD-JPY »

FX Action: USD-JPY topped…

NWL

Newell Brands

$19.31

0.14 (0.73%)

12:25
10/16/19
10/16
12:25
10/16/19
12:25
Options
Newell Brands call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GM

General Motors

$37.04

0.77 (2.12%)

12:18
10/16/19
10/16
12:18
10/16/19
12:18
Hot Stocks
General Motors confirms UAW's statement regarding proposed tentative agreement »

GM said in a statement:…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Oct

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

12:17
10/16/19
10/16
12:17
10/16/19
12:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

12:16
10/16/19
10/16
12:16
10/16/19
12:16
Technical Analysis
NYSE market internals summary »

Volume is below average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PLAN

Anaplan

$44.40

-3.33 (-6.98%)

12:15
10/16/19
10/16
12:15
10/16/19
12:15
Options
Anaplan put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Oct

  • 17

    Oct

MCK

McKesson

$146.86

8.69 (6.29%)

, ABC

AmerisourceBergen

$87.62

4.44 (5.34%)

12:11
10/16/19
10/16
12:11
10/16/19
12:11
On The Fly
Fly Intel: Wall Street's top stories at midday »

Stocks continue in a…

MCK

McKesson

$146.86

8.69 (6.29%)

ABC

AmerisourceBergen

$87.62

4.44 (5.34%)

CAH

Cardinal Health

$49.76

1.83 (3.82%)

JNJ

Johnson & Johnson

$136.44

3.6 (2.71%)

TEVA

Teva

$7.33

0.37 (5.32%)

GM

General Motors

$37.14

0.87 (2.40%)

UAL

United Airlines

$90.00

2.1 (2.39%)

BA

Boeing

$376.35

5.36 (1.44%)

BAC

Bank of America

$30.38

0.64 (2.15%)

MGM

MGM Resorts

$27.47

-0.4 (-1.44%)

BX

Blackstone

$46.86

-0.24 (-0.51%)

ACHN

Achillion

$6.25

2.595 (71.00%)

ALXN

Alexion

$102.60

-2.245 (-2.14%)

SFIX

Stitch Fix

$22.00

1.17 (5.62%)

WDAY

Workday

$158.51

-22.33 (-12.35%)

SNBR

Sleep Number

$45.49

-1.2 (-2.57%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Oct

  • 16

    Oct

  • 16

    Oct

  • 16

    Oct

  • 16

    Oct

  • 19

    Oct

  • 22

    Oct

  • 23

    Oct

  • 23

    Oct

  • 23

    Oct

  • 23

    Oct

  • 29

    Oct

  • 30

    Oct

  • 30

    Oct

  • 06

    Nov

  • 07

    Nov

  • 07

    Nov

  • 07

    Nov

  • 12

    Nov

  • 12

    Nov

WB

Weibo

$52.17

2.85 (5.78%)

12:05
10/16/19
10/16
12:05
10/16/19
12:05
Options
Weibo call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

APHA

Aphria

$5.00

-0.41 (-7.58%)

12:00
10/16/19
10/16
12:00
10/16/19
12:00
Hot Stocks
Aphria falls -8.1% »

Aphria is down -8.1%, or…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

NOW

ServiceNow

$251.40

-23.2 (-8.45%)

12:00
10/16/19
10/16
12:00
10/16/19
12:00
Hot Stocks
ServiceNow falls -8.3% »

ServiceNow is down -8.3%,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 12

    Dec

AVD

American Vanguard

$13.39

-1.87 (-12.25%)

12:00
10/16/19
10/16
12:00
10/16/19
12:00
Hot Stocks
American Vanguard falls -12.6% »

American Vanguard is down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Nov

  • 19

    Nov

  • 20

    Nov

HOV

Hovnanian

$28.26

2.2 (8.44%)

12:00
10/16/19
10/16
12:00
10/16/19
12:00
Hot Stocks
Hovnanian rises 8.2% »

Hovnanian is up 8.2%, or…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

OMI

Owens & Minor

$6.98

0.55 (8.55%)

12:00
10/16/19
10/16
12:00
10/16/19
12:00
Hot Stocks
Owens & Minor rises 8.2% »

Owens & Minor is up…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FIT

Fitbit

$3.75

0.305 (8.85%)

12:00
10/16/19
10/16
12:00
10/16/19
12:00
Hot Stocks
Fitbit rises 8.7% »

Fitbit is up 8.7%, or 30c…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GM

General Motors

$37.17

0.9 (2.48%)

11:57
10/16/19
10/16
11:57
10/16/19
11:57
Hot Stocks
UAW sends proposed tentative deal to UAW GM members to ratify »

Following five weeks of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Oct

PDCO

Patterson Companies

$17.42

0.09 (0.52%)

, HSIC

Henry Schein

$62.68

0.83 (1.34%)

11:55
10/16/19
10/16
11:55
10/16/19
11:55
Hot Stocks
Judge rules Patterson Companies violated U.S. antitrust laws in FTC complaint »

Chief Administrative Law…

PDCO

Patterson Companies

$17.42

0.09 (0.52%)

HSIC

Henry Schein

$62.68

0.83 (1.34%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Nov

  • 12

    Dec

HSIC

Henry Schein

$62.41

0.56 (0.91%)

11:50
10/16/19
10/16
11:50
10/16/19
11:50
Hot Stocks
Judge dismisses FTC complaint against Henry Schein »

Chief Administrative Law…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Nov

  • 12

    Dec

XLF

Financial Select Sector

$28.06

-0.02 (-0.07%)

11:50
10/16/19
10/16
11:50
10/16/19
11:50
Options
Upside call buyer in Financial Sector ETF tied to hedge »

Upside call buyer in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IRBT

iRobot

$58.37

0.58 (1.00%)

11:48
10/16/19
10/16
11:48
10/16/19
11:48
Hot Stocks
SharkNinja says 'will aggressively defend' against iRobot patent suit »

SharkNinja announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 13

    Nov

RNET

RigNet

11:46
10/16/19
10/16
11:46
10/16/19
11:46
Initiation
RigNet initiated  »

RigNet initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ATNI

ATN International

11:46
10/16/19
10/16
11:46
10/16/19
11:46
Initiation
ATN International initiated  »

ATN International…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.